News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ulthera CEO - Matthew Likens - to Present at Two Upcoming Healthcare Conferences


11/22/2011 11:30:48 AM

MESA, Ariz., Nov. 22, 2011 /PRNewswire/ -- Matthew Likens, president and CEO of Ulthera, Inc. a global, commercial-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology is scheduled to present at two upcoming healthcare conferences:

-- Tuesday, Nov. 29 at 2:10 p.m. EST

23rd Annual Piper Jaffray Healthcare Conference in New York City, Nov. 29-30, 2011

Location: The New York Palace Hotel, 455 Madison Avenue, New York 10022

-- Tuesday, Dec. 6 at 12:00 p.m. PT

6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference in San Francisco, Dec. 6, 2011

Location: St. Regis, 125 3rd Street, San Francisco 94103

Likens will present an overview of the company as well as its accomplishments to date and prospects for the future.

(Logo: http://photos.prnewswire.com/prnh/20111122/NY10856LOGO )

About Ulthera
Ulthera®, Inc. is a global, commercial-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology. The Ulthera® System is the first and only energy-based device to receive FDA clearance for a non-invasive aesthetic lift indication. The first application for Ultherapy® the procedure enabled by the System is a non-invasive face and neck treatment to achieve a brow lift. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company backed by top tier venture capital firms, New Enterprise Associates and Apposite Capital. For more information, visit www.ulthera.com.

SOURCE Ulthera, Inc.


Read at BioSpace.com


comments powered by Disqus
Ulthera
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES